Ratings by Jefferies (Michael J. Yee)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/22/2023 | Cerevel Therapeutics | CERE | Downgrade | Hold (Buy) |
41.32 (44.96) |
8.81% | Details | |
| 6/15/2023 | Schrodinger | SDGR | Maintain | Buy (N/A) |
|
Details | ||
| 4/18/2022 | Schrodinger | SDGR | Maintain | Buy (N/A) |
|
Details | ||
| 11/11/2021 | Schrodinger | SDGR | Maintain | Buy (N/A) |
|
Details | ||
| 10/7/2021 | Cerevel Therapeutics | CERE | Maintain | Buy (N/A) |
|
Details | ||
| 4/12/2021 | Schrodinger | SDGR | Maintain | Buy (N/A) |
|
Details | ||
| 3/15/2021 | Schrodinger | SDGR | Maintain | Buy (N/A) |
|
Details | ||
| 12/21/2020 | Schrodinger | SDGR | Maintain | Buy (N/A) |
|
Details | ||
| 12/21/2020 | Epizyme | EPZM | Downgrade | Hold (Buy) |
12.74 (1.47) |
-88.46% | Details | |
| 12/21/2020 | Intercept Pharmaceuticals | ICPT | Downgrade | Hold (Buy) |
30.28 (19.00) |
-37.25% | Details | |
| 10/12/2020 | Schrodinger | SDGR | Upgrade | Buy (Hold) |
56.72 (15.04) |
-73.48% | Details | |
| 8/10/2020 | Schrodinger | SDGR | Maintain | Hold (N/A) |
|
Details | ||
| 8/4/2020 | Epizyme | EPZM | Maintain | Buy (N/A) |
|
Details | ||
| 6/29/2020 | Intercept Pharmaceuticals | ICPT | Maintain | Buy (N/A) |
|
Details | ||
| 6/10/2020 | Axovant Gene Therapies | AXGT | Maintain | Buy (N/A) |
|
Details | ||
| 5/13/2020 | Schrodinger | SDGR | Maintain | Hold (N/A) |
|
Details |
